Debut Plus

₹816.4

▼ -0.98 -0.12%

As of 09 Sept 2026 · delayed

NSE Listed

Alembic Pharmaceuticals Ltd. (APLLTD)

Volume: 86,236Avg Vol 1W: 1,59,167.8Avg Vol 1M: 1,09,016.752W Range:₹635.8₹998
NSE BSE www.alembicpharmaceuticals.com AI Report
Key Ratios
Checked 8h ago
Market Cap₹16,067 Cr
Current Price₹816.4
Previous Close₹817.38
High / Low (52w)₹998 / ₹635.8
Volume86,236
Avg Vol (1W)1,59,167.8
Avg Vol (1M)1,09,016.7
Stock P/E21.53
Book Value₹288.7
Dividend Yield147%
ROE11.89%
ROA7.87%
Revenue (TTM)₹6,715 Cr
Revenue Growth7.1%
Profit Margin8.91%
Total Debt₹0 Cr
Shares Outstanding20 Cr
Face Value₹2
EPS (TTM)₹37.96
P/B2.83
Debt / Equity0.25
50 DMA₹821.72
200 DMA₹782.45
Day change-0.12%
Price Chart
₹816.4▼ 14.24% · 1Y
₹978₹64740.1L
2025-09-10
2026-09-09

20-day avg volume: 1.1L shares

Pros
  • Pays a dividend yield of 147.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 16% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹1,648 Cr₹1,693 Cr₹1,770 Cr₹1,711 Cr₹1,910 Cr₹1,876 Cr₹1,848 Cr₹2,150 Cr
EBITDA₹186 Cr₹200 Cr₹217 Cr₹214 Cr₹247 Cr₹229 Cr₹165 Cr₹249 Cr
Net Profit₹153 Cr₹138 Cr₹157 Cr₹154 Cr₹185 Cr₹133 Cr₹203 Cr₹173 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹6,715 Cr₹1,571 Cr₹1,494 Cr₹1,796 Cr₹1,642 Cr₹1,719 Cr₹7,399 Cr₹1,868 Cr
EBITDA₹772 Cr₹115 Cr₹148 Cr₹239 Cr₹203 Cr₹218 Cr₹854 Cr₹277 Cr
Net Profit₹583 Cr₹75 Cr₹104 Cr₹179 Cr₹114 Cr₹243 Cr₹675 Cr₹197 Cr
EPS29.68—————34.33—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹4,778 Cr₹5,989 Cr₹6,709 Cr₹7,122 Cr₹6,183 Cr₹6,446 Cr₹7,773 Cr₹8,763 Cr
Total Liabilities₹2,060 Cr₹2,799 Cr₹1,642 Cr₹1,884 Cr₹1,812 Cr₹1,627 Cr₹2,583 Cr₹3,094 Cr
Equity₹2,718 Cr₹3,190 Cr₹5,067 Cr₹5,238 Cr₹4,370 Cr₹4,818 Cr₹5,190 Cr₹5,669 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹978 Cr₹685 Cr₹1,709 Cr₹676 Cr₹785 Cr₹823 Cr₹159 Cr₹886 Cr
Investing₹-756 Cr₹-732 Cr₹-839 Cr₹-372 Cr₹-448 Cr₹-321 Cr₹-568 Cr₹-506 Cr
Financing₹59 Cr₹155 Cr₹-597 Cr₹-217 Cr₹-262 Cr₹-438 Cr₹444 Cr₹-164 Cr
Free Cash Flow₹978 Cr₹685 Cr₹1,709 Cr₹676 Cr₹785 Cr₹823 Cr₹159 Cr₹886 Cr
Shareholding
Promoter 69.87% Institutions 20.12% Public 10.01%
Efficiency & Working Capital
ROCE10.8%
Interest Coverage8.4
Dividend Payout—
Debtor Days73 d
Inventory Days125 d
Payable Days41 d
Cash Conversion Cycle156 d
Working Capital Days198 d
Shareholding Details

As of 2026-06-30

Promoter69.9%
FII4.2%
DII15.9%
Institutions20.1%
Public10%
Promoter Pledge0%
No. of Shareholders86,796
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters69.6%69.6%69.6%69.6%69.6%69.6%69.7%69.7%69.7%69.7%69.7%69.9%
FIIs4.5%4.5%4.5%4.3%3.9%4.2%3.9%4%4%4.2%4.3%4.2%
DIIs13.9%14.5%15.4%15.5%16.1%16.1%16.4%16.5%16.3%16.2%16.2%15.9%
Public12%11.4%10.5%10.6%10.4%10.2%10%9.9%9.9%9.9%9.8%10%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders89,55285,21276,56774,82991,42993,94491,33689,01389,96987,00086,43286,796
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Nirayu Private LimitedShareholding of Promoter and Promoter Group35.8%7.03 Cr
Alembic LimitedShareholding of Promoter and Promoter Group28.5%5.61 Cr
Life Insurance Corporation Of IndiaPublic Shareholding4.3%84,95,125
Dsp Small Cap FundPublic Shareholding3.9%75,85,888
Chirayu Ramanbhai AminShareholding of Promoter and Promoter Group2.1%41,92,529
Kotak Small Cap FundPublic Shareholding1.7%34,27,766
Malika Chirayu AminShareholding of Promoter and Promoter Group1.5%30,05,730
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding1.4%27,12,515
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap FundPublic Shareholding1.2%22,64,405
Udit Chirayu AminShareholding of Promoter and Promoter Group0.5%10,06,980
Pranav Chirayu AminShareholding of Promoter and Promoter Group0.5%10,09,800
Shaunak Chirayu AminShareholding of Promoter and Promoter Group0.5%10,06,980
Chirayu Ramanbhai Amin HufShareholding of Promoter and Promoter Group0.1%2,18,295
Gallup Trust (pranav Chirayu Amin)Shareholding of Promoter and Promoter Group0.1%1,00,100
Inaaya Shaunak AminShareholding of Promoter and Promoter Group0%80,000
Naintara Shaunak AminShareholding of Promoter and Promoter Group0%80,000
Barkha Pranav AminShareholding of Promoter and Promoter Group0%50,100
Krupa Shaunak AminShareholding of Promoter and Promoter Group0%50,100
Satori Trust (chirayu Ramanbhai Amin)Shareholding of Promoter and Promoter Group0%50,100
Ranvir Pranav AminShareholding of Promoter and Promoter Group0%30,000
Samira Pranav AminShareholding of Promoter and Promoter Group0%30,000
Paushak LimitedShareholding of Promoter and Promoter Group0%855
Alembic City LimitedShareholding of Promoter and Promoter Group0%100
Shreno Publications LimitedShareholding of Promoter and Promoter Group0%100
Shreno Engineering LimitedShareholding of Promoter and Promoter Group0%100
Board of Directors
NameDesignationYear
C R AminExecutive Chairman2026
Rajkumar BahetiNon Independent Executive Director / CFO2026
Pranav AminED / MD / Promoter2026
Shaunak AminED / MD / Promoter2026
Ashok BaratIndependent Non Exe. Director2026
Jai Shishir DiwanjiIndependent Non Exe. Director2026
Manish KejriwalIndependent Non Exe. Director2026
Geeta GoradiaIndependent Non Exe. Director2026
Sujit J BhayaniIndependent Director2026
MANISHA SARAFCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2413939
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-04Board Meetings—
forthcoming2026-07-29Dividend (12/- per share)Final
dividend2026-07-29₹12 (600%)Final
dividend2025-07-29₹11 (550%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202650600684451,023
202645100021472
2026410068423537
Insider / Designated-Person Trades

13 recent disclosure(s)

Nirayu Private LimitedAcquisition · 3,278
Nirayu Private LimitedAcquisition · 24,832
Nirayu Private LimitedAcquisition · 75,000
Nirayu Private LimitedAcquisition · 20,000
Nirayu Private LimitedAcquisition · 78,000
Nirayu Private LimitedAcquisition · 60,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market24/11/2023 · 36,276
Company Information
Incorporated2010
ChairmanC R Amin
AuditorKKC & Associates LLP
Investor Email[email protected]
🌐 www.alembicpharmaceuticals.com ↗

📍 Alembic Road, Vadodara, Gujarat, 390003

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Apar Industries Ltd.Anjani Portland Cement Ltd.Apcotex Industries LimitedApex Frozen Foods LimitedApex Ecotech LimitedAPL Apollo Tubes Ltd.Apollo Micro Systems Ltd.Apollo Hospitals Enter. LimitedApollo Pipes LimitedApollo Tyres Ltd.Apollo Sindoori Hotel Ltd.Apoorva Leasing Finance & Investment Co Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search